Observational Study
Copyright ©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1480-1494
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1480
Figure 5
Figure 5 Survival rate with or without pre-sarcopenia. The liver disease-related survival rate was divided into two groups according to the presence of pre-sarcopenia before radiofrequency ablation. A: Hepatitis C virus (HCV)-positive group; B: HCV-negative group. The gray line indicates patients without pre-sarcopenia, and the black line indicates patients with pre-sarcopenia. The numbers under each group indicate the number at risk for each group. HCV: Hepatitis C virus; M2BPGi: Mac-2 binding protein; M2BPGi: Mac-2 binding protein glycosylation isomer; NS: No significance.